Skyward Specialty Insurance Group, Inc.

SKWD

CIK 0001519449 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$386M
↑+26.7% +$81Mvs FY2024 (Q4)
Operating Income
$386M
↑+26.7% +$81Mvs FY2024 (Q4)
Net Income
$43M
↑+200.1% +$29Mvs FY2024 (Q4)
Gross Profit
$386M
↑+26.7% +$81Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
18/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    10Asset Turnover 0.33x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +26.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project SKWD's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 24.9%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$321.21
Total enterprise IV
$13.43B
Diluted shares
0.04B
Terminal PV
$10.43B (78% of total)
Year-5 FCF
$1.23B
YearProjected FCFDiscounted PV
+1$503M$458M
+2$629M$520M
+3$786M$591M
+4$983M$671M
+5$1.23B$763M
Terminal$16.79B$10.43B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$5M
investment in PP&E

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$4.79B
everything owned
Total liabilities
$3.78B
everything owed
Stockholders' equity
$1.01B
shareholder claim

Recent performance · 17 quarters

Revenue↑+26.7% +$81M
$386M
Net Income↑+200.1% +$29M
$43M
Free Cash Flow↑+140.4% +$29M
$50M

Drill down